Skip to Content

Gate 322 Lofibra 67 mg (Lofibra 67 mg)

Generic Name: fenofibrate

Pill with imprint Gate 322 Lofibra 67 mg is Pink, Capsule-shape and has been identified as Lofibra 67 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 67 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Gate 322 Lofibra 67 mg

Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra 67 mg Gate 322 Lofibra 67 mg


Generic Name:
Gate 322 Lofibra 67 mg
67 mg
14.00 mm
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gate Pharmaceuticals
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
povidone k25
corn starch
sodium lauryl sulfate
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.